325 related articles for article (PubMed ID: 31339295)
1. Sequentially Site-Specific Delivery of Thrombolytics and Neuroprotectant for Enhanced Treatment of Ischemic Stroke.
Xu J; Wang X; Yin H; Cao X; Hu Q; Lv W; Xu Q; Gu Z; Xin H
ACS Nano; 2019 Aug; 13(8):8577-8588. PubMed ID: 31339295
[TBL] [Abstract][Full Text] [Related]
2. Bioengineered Boronic Ester Modified Dextran Polymer Nanoparticles as Reactive Oxygen Species Responsive Nanocarrier for Ischemic Stroke Treatment.
Lv W; Xu J; Wang X; Li X; Xu Q; Xin H
ACS Nano; 2018 Jun; 12(6):5417-5426. PubMed ID: 29869497
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Tissue Plasminogen Activator-conjugated Nanoparticles Effectively Targets Thrombolysis in a Rat Model of Middle Cerebral Artery Occlusion.
Deng J; Mei H; Shi W; Pang ZQ; Zhang B; Guo T; Wang HF; Jiang XG; Hu Y
Curr Med Sci; 2018 Jun; 38(3):427-435. PubMed ID: 30074208
[TBL] [Abstract][Full Text] [Related]
4. The JNK inhibitor XG-102 protects from ischemic damage with delayed intravenous administration also in the presence of recombinant tissue plasminogen activator.
Wiegler K; Bonny C; Coquoz D; Hirt L
Cerebrovasc Dis; 2008; 26(4):360-6. PubMed ID: 18728363
[TBL] [Abstract][Full Text] [Related]
5. Polyacrylic acid-coated nanoparticles loaded with recombinant tissue plasminogen activator for the treatment of mice with ischemic stroke.
Huang L; Wang J; Huang S; Siaw-Debrah F; Nyanzu M; Zhuge Q
Biochem Biophys Res Commun; 2019 Aug; 516(2):565-570. PubMed ID: 31235258
[TBL] [Abstract][Full Text] [Related]
6. Canonical Wnt Pathway Maintains Blood-Brain Barrier Integrity upon Ischemic Stroke and Its Activation Ameliorates Tissue Plasminogen Activator Therapy.
Jean LeBlanc N; Menet R; Picard K; Parent G; Tremblay MÈ; ElAli A
Mol Neurobiol; 2019 Sep; 56(9):6521-6538. PubMed ID: 30852795
[TBL] [Abstract][Full Text] [Related]
7. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke.
Tanne D; Macko RF; Lin Y; Tilley BC; Levine SR;
Stroke; 2006 Jul; 37(7):1798-804. PubMed ID: 16763191
[TBL] [Abstract][Full Text] [Related]
8. Preparation of Peptide and Recombinant Tissue Plasminogen Activator Conjugated Poly(Lactic-Co-Glycolic Acid) (PLGA) Magnetic Nanoparticles for Dual Targeted Thrombolytic Therapy.
Chen HA; Ma YH; Hsu TY; Chen JP
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32294917
[TBL] [Abstract][Full Text] [Related]
9. Thrombolysis and neuroprotection in cerebral ischemia.
Gutiérrez M; Díez Tejedor E; Alonso de Leciñana M; Fuentes B; Carceller F; Roda JM
Cerebrovasc Dis; 2006; 21 Suppl 2():118-26. PubMed ID: 16651822
[TBL] [Abstract][Full Text] [Related]
10. GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats.
Wang W; Li M; Wang Y; Li Q; Deng G; Wan J; Yang Q; Chen Q; Wang J
Mol Neurobiol; 2016 Dec; 53(10):7028-7036. PubMed ID: 26671619
[TBL] [Abstract][Full Text] [Related]
11. Suppression of NLRP3 attenuates hemorrhagic transformation after delayed rtPA treatment in thromboembolic stroke rats: Involvement of neutrophil recruitment.
Guo Z; Yu S; Chen X; Zheng P; Hu T; Duan Z; Liu X; Liu Q; Ye R; Zhu W; Liu X
Brain Res Bull; 2018 Mar; 137():229-240. PubMed ID: 29258866
[TBL] [Abstract][Full Text] [Related]
12. Prothrombolytic action of normobaric oxygen given alone or in combination with recombinant tissue-plasminogen activator in a rat model of thromboembolic stroke.
David HN; Haelewyn B; Degoulet M; Colomb DG; Risso JJ; Abraini JH
J Appl Physiol (1985); 2012 Jun; 112(12):2068-76. PubMed ID: 22492935
[TBL] [Abstract][Full Text] [Related]
13. Enhanced Cerebroprotection of Xenon-Loaded Liposomes in Combination with rtPA Thrombolysis for Embolic Ischemic Stroke.
Peng T; Booher K; Moody MR; Yin X; Aronowski J; McPherson DD; Savitz SI; Kim H; Huang SL
Biomolecules; 2023 Aug; 13(8):. PubMed ID: 37627321
[TBL] [Abstract][Full Text] [Related]
14. Recombinant tissue-type plasminogen activator transiently enhances blood-brain barrier permeability during cerebral ischemia through vascular endothelial growth factor-mediated endothelial endocytosis in mice.
Suzuki Y; Nagai N; Yamakawa K; Muranaka Y; Hokamura K; Umemura K
J Cereb Blood Flow Metab; 2015 Dec; 35(12):2021-31. PubMed ID: 26219596
[TBL] [Abstract][Full Text] [Related]
15. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
[TBL] [Abstract][Full Text] [Related]
16. Recombinant Plasminogen Activator Modified Nanoparticles for Targeting Thrombolysis in Branch Retinal Vein Occlusion.
Zhang H; Han S; Zhang L; Guo Y; Li Y
Cell Mol Biol (Noisy-le-grand); 2022 Mar; 68(3):201-212. PubMed ID: 35988180
[TBL] [Abstract][Full Text] [Related]
17. Sub-acute systemic erythropoietin administration reduces ischemic brain injury in an age-dependent manner.
Thériault P; Le Béhot A; ElAli A; Rivest S
Oncotarget; 2016 Jun; 7(24):35552-35561. PubMed ID: 27248662
[TBL] [Abstract][Full Text] [Related]
18. Thrombolytic therapy based on lyophilized platelet-derived nanocarriers for ischemic stroke.
Migliavacca M; Correa-Paz C; Pérez-Mato M; Bielawski PB; Zhang I; Marie P; Hervella P; Rubio M; Maysinger D; Vivien D; Del Pino P; Pelaz B; Polo E; Campos F
J Nanobiotechnology; 2024 Jan; 22(1):10. PubMed ID: 38166940
[TBL] [Abstract][Full Text] [Related]
19. Magnetically targeted thrombolysis with recombinant tissue plasminogen activator bound to polyacrylic acid-coated nanoparticles.
Ma YH; Wu SY; Wu T; Chang YJ; Hua MY; Chen JP
Biomaterials; 2009 Jul; 30(19):3343-51. PubMed ID: 19299010
[TBL] [Abstract][Full Text] [Related]
20. Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke.
Morris DC; Zhang L; Zhang ZG; Lu M; Berens KL; Brown PM; Chopp M
Stroke; 2001 Nov; 32(11):2635-40. PubMed ID: 11692028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
